PVI

Pura Vida Investments Portfolio holdings

AUM $16.6M
1-Year Return 3.82%
This Quarter Return
-1.19%
1 Year Return
-3.82%
3 Year Return
-0.02%
5 Year Return
+29.84%
10 Year Return
+256.58%
AUM
$828M
AUM Growth
-$131M
Cap. Flow
-$56.7M
Cap. Flow %
-6.85%
Top 10 Hldgs %
49.76%
Holding
264
New
28
Increased
49
Reduced
25
Closed
53

Sector Composition

1 Healthcare 89.68%
2 Materials 1.3%
3 Industrials 0.61%
4 Consumer Discretionary 0.26%
5 Financials 0.19%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
OYST
126
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
-41,130
Closed -$751K
RACB
127
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
-503,955
Closed -$4.9M
LOGC
128
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
-230,121
Closed -$532K
CCXI
129
DELISTED
ChemoCentryx, Inc.
CCXI
-28,118
Closed -$1.02M
RDUS
130
DELISTED
Radius Health, Inc.
RDUS
-124,607
Closed -$862K
SRRA
131
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
-71,320
Closed -$1.55M
AVEO
132
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
-123,416
Closed -$579K
AVXL icon
133
Anavex Life Sciences
AVXL
$807M
0
AZTA icon
134
Azenta
AZTA
$1.39B
0
BAX icon
135
Baxter International
BAX
$12.5B
0
BDX icon
136
Becton Dickinson
BDX
$55.1B
0
BEAM icon
137
Beam Therapeutics
BEAM
$2.11B
-13,978
Closed -$1.11M
PSTX
138
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-89,886
Closed -$612K
AXNX
139
DELISTED
Axonics, Inc. Common Stock
AXNX
0
TBIO
140
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
-31,794
Closed -$6.18M
ARYD
141
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
-510,507
Closed -$5.06M
ACAD icon
142
Acadia Pharmaceuticals
ACAD
$4.26B
-50,000
Closed -$1.17M
ACIU icon
143
AC Immune
ACIU
$229M
-33,997
Closed -$168K
ACRS icon
144
Aclaris Therapeutics
ACRS
$227M
-48,266
Closed -$702K
ABBV icon
145
AbbVie
ABBV
$375B
0
ABT icon
146
Abbott
ABT
$231B
0
A icon
147
Agilent Technologies
A
$36.5B
0
AGEN
148
Agenus
AGEN
$138M
0
AHCO icon
149
AdaptHealth
AHCO
$1.29B
0
ALC icon
150
Alcon
ALC
$39.6B
0